Investigation on bioactivity and cytotoxicity of mesoporous nano-composite MCM-48/hydroxyapatite for ibuprofen drug delivery
Source abstract
Abstract
Abstract A novel in situ synthesis is presented of a hydroxyapatite composite with the mesoporous silicate MCM-48 with potential applications as a drug delivery agent. The structure and properties of this nanocomposite, investigated by a number of techniques including XRD, SEM and TEM, show the intergrowth of the hydroxyapatite particles with the silica structure. The bioactivity of the new material was determined by measuring the decrease in the calcium ion concentration of simulated body fluid (SBF) after soaking the nanocomposite, while the uptake of ibuprofen on MCM-48 and MCM-48/HAp composite from ethanol was monitored by UV spectroscopy at 222 nm which was also used to monitor the release of ibuprofen into SBF, MTT assay was used to assess effect of the sample on MG68 cell live proliferation. The results confirm the successful synthesis of a MCM-48/hydroxyapatite nanocomposite and its potential biomedical applications as a bioactive ceramic and as a drug delivery agent with a higher rate of ibuprofen release compared to MCM-48.
Source: openaire · Quality: candidate unverified · Source record ↗
Research context
OpenAlex topics: Bone Tissue Engineering Materials · Mesoporous Materials and Catalysis · biodegradable polymer synthesis and properties
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (35)
Show source-provided references
1. Recent advances in functionalization of mesoporous silica10.1166/jnn.2005.089 ↗
2. A new property of MCM-41: drug delivery system10.1021/cm0011559 ↗
3. Polymeric systems for controlled drug release10.1021/cr940351u ↗
4. Development of porous spherical hydroxyapatite granules: application towards protein delivery10.1023/A:1008918412198 ↗
5. Mesoporous silica nanoparticles for drug delivery and biosensing applications10.1002/adfm.200601191 ↗
6. Synthesis of antibiotic-loaded interporous hydroxyapatite blocks by vacuum method and in vitro drug release testing10.1016/S0142-9612(97)00237-8 ↗
7. Nanocrystalline hydroxyapatite and calcium sulphate as biodegradable composite carrier material for local delivery of antibiotics in bone infections10.1016/j.biomaterials.2004.06.045 ↗
8. A new method to produce macropores in calcium–phosphate cements10.1016/S0142-9612(02)00101-1 ↗
9. Calcium orthophosphates in medicine: from ceramics to calcium phosphate cements10.1016/S0020-1383(00)80022-4 ↗
10. Flow injection fluorescence immunoassay for gentamicin using sol–gel derived mesoporous biomaterial10.1016/S0003-2697(02)00222-1 ↗
11. Controlled release of biomolecules from temperature-sensitive hydrogels prepared by radiation polymerization10.1016/S0168-3659(01)00380-7 ↗
12. The effect of composition of poly(acrylic acid)–gelatin hydrogel on gentamicin sulphate release: in vitro10.1016/S0142-9612(02)00364-2 ↗
13. MCM-41 organic modification as drug delivery rate regulator10.1021/cm021217q ↗
14. A controlled release of ibuprofen by systematically tailoring the morphology of mesoporous silica materials10.1016/j.jssc.2006.04.002 ↗
15. Mesoporous silica nanoparticle based nano drug delivery systems: synthesis,controlled drug release and delivery, pharmacokinetics and biocompatibility10.1039/c0jm03851b ↗
16. Preparation of mesoporous calcium doped silica spheres with narrow size dispersion and their drug loading and degradation behavior10.1016/j.micromeso.2006.12.048 ↗
17. A new family of mesoporous molecular sieves prepared with liquid crystal templates10.1021/ja00053a020 ↗
18. B.A. Aufdembrink, A.W. Chester, J.A. Herbst, C.T. Kresge: US Patent 5, 258 (1993) 114.
19. Trens Studies on the formation and properties of some highly ordered mesoporous solids10.1016/S0167-2991(00)80056-7 ↗
20. Transition metal containing mesoporous silicas – redox properties, structure and catalytic activity10.1016/S1387-1811(01)00203-7 ↗
21. Conducting polyaniline filaments in a mesoporous channel host10.1126/science.264.5166.1757 ↗
22. Structure of MCM-48 revealed by transmission electron microscopy10.1021/cm950568k ↗
23. Cooperative formation of inorganic-organic interfaces in the synthesis of silicate mesostructures10.1126/science.261.5126.1299 ↗
24. Tissue regeneration: a new property of mesoporous materials10.1016/j.solidstatesciences.2005.04.003 ↗
25. Influence of mesoporous structure type on the controlled delivery of drugs: release of ibuprofen from MCM-48, SBA-15 and functionalized SBA-1510.1007/s10971-009-1932-3 ↗
26. Surface-active biomaterials10.1126/science.6093253 ↗
27. Processing and properties of hydroxyapatite based biomaterials for use as hard tissue replacement implants10.1557/JMR.1998.0015 ↗
28. Release evaluation of drugs from ordered three-dimensional silica structures10.1016/j.ejps.2005.06.009 ↗
29. Novel bioactive materials with different mechanical properties10.1016/S0142-9612(03)00044-9 ↗
30. Synthesis of MCM-48 single crystals10.1039/a707677k ↗
31. Influence of different structured channels of mesoporous silicate on the controlled ibuprofen delivery10.1016/j.matchemphys.2012.05.059 ↗
32. In vitro evaluation of (S)- ibuprofen toxicity on joint cells and explants of cartilage and synovial membrane10.1016/j.tiv.2011.06.018 ↗
33. Effects of nonselective cyclooxygenase inhibition with low-dose ibuprofen on tumor growth, angiogenesis, metastasis, and survival in a mouse model of colorectal cancer10.1158/1078-0432.CCR-04-1696 ↗
34. Evidence of COX-2 independent induction of apoptosis and cell cycle block in human colon carcinoma cells after S- or R-ibuprofen treatment10.1016/j.ejphar.2006.04.030 ↗
35. Zawidlak-Wegrzynska · Eur. J. Med. Chem. · 2010 · 45 · 183310.1016/j.ejmech.2010.01.020 ↗